ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 111 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $869 | -20.4% | 130,044 | 0.0% | 0.05% | -14.5% |
| Q2 2023 | $1,092 | +3.3% | 130,044 | +22.2% | 0.06% | +17.0% |
| Q1 2023 | $1,057 | +42.6% | 106,456 | +0.1% | 0.05% | +30.6% |
| Q4 2022 | $741 | -99.9% | 106,400 | -1.5% | 0.04% | +28.6% |
| Q3 2022 | $577,000 | +33.9% | 108,000 | 0.0% | 0.03% | +47.4% |
| Q2 2022 | $431,000 | -10.2% | 108,000 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $480,000 | -2.6% | 108,000 | -12.3% | 0.02% | +26.7% |
| Q4 2021 | $493,000 | -16.4% | 123,200 | +83.6% | 0.02% | -21.1% |
| Q3 2021 | $590,000 | -23.1% | 67,100 | -0.9% | 0.02% | -26.9% |
| Q2 2021 | $767,000 | – | 67,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,877,305 | $10,025,000 | 5.86% |
| Prosight Management, LP | 1,210,800 | $6,466,000 | 3.46% |
| Perceptive Advisors | 11,350,085 | $60,609,000 | 1.76% |
| JOHNSON & JOHNSON | 394,834 | $2,108,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $3,738,000 | 0.46% |
| APOGEM CAPITAL LLC | 85,091 | $454,000 | 0.45% |
| 683 Capital Management, LLC | 700,000 | $3,738,000 | 0.29% |
| EAM Investors, LLC | 233,638 | $1,248,000 | 0.27% |
| Verition Fund Management LLC | 4,804,478 | $12,840,828 | 0.14% |
| WOODSTOCK CORP | 129,179 | $690,000 | 0.10% |